ALNYLAM PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss

The total revenue of ALNY for the last quarter is 9.87 B MXN, and it's 18.45% lower compared to the previous quarter. The net income of Q3 24 is -2.20 B MXN.